190 related articles for article (PubMed ID: 18937916)
21. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
Bank A; Dorazio R; Leboulch P
Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
[TBL] [Abstract][Full Text] [Related]
22. β-Thalassemia due to intronic LINE-1 insertion in the β-globin gene (HBB): molecular mechanisms underlying reduced transcript levels of the β-globin(L1) allele.
Lanikova L; Kucerova J; Indrak K; Divoka M; Issa JP; Papayannopoulou T; Prchal JT; Divoky V
Hum Mutat; 2013 Oct; 34(10):1361-5. PubMed ID: 23878091
[TBL] [Abstract][Full Text] [Related]
23. A humanized mouse model for a common beta0-thalassemia mutation.
Jamsai D; Zaibak F; Khongnium W; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Fucharoen S; Williamson R; Ioannou PA
Genomics; 2005 Apr; 85(4):453-61. PubMed ID: 15780748
[TBL] [Abstract][Full Text] [Related]
24. Generation of an in vitro model of β-thalassemia using the CRISPR/Cas9 genome editing system.
Ajami M; Atashi A; Kaviani S; Kiani J; Soleimani M
J Cell Biochem; 2020 Feb; 121(2):1420-1430. PubMed ID: 31596028
[TBL] [Abstract][Full Text] [Related]
25. alpha/beta-Globin mRNA ratio determination by multiplex quantitative real-time reverse transcription-polymerase chain reaction as an indicator of globin gene function.
Chaisue C; Kitcharoen S; Wilairat P; Jetsrisuparb A; Fucharoen G; Fucharoen S
Clin Biochem; 2007 Dec; 40(18):1373-7. PubMed ID: 17920577
[TBL] [Abstract][Full Text] [Related]
26. Hemoglobin gene therapy for β-thalassemia.
Bank A
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of alpha-globin gene expression by RNAi.
Sarakul O; Vattanaviboon P; Wilairat P; Fucharoen S; Abe Y; Muta K
Biochem Biophys Res Commun; 2008 May; 369(3):935-8. PubMed ID: 18328259
[TBL] [Abstract][Full Text] [Related]
28. [Expression of human betaIVS- II -nt 654 C --> T allele in HeLa cell].
Chen W; Gu X; Sun Q
Zhonghua Xue Ye Xue Za Zhi; 1997 Oct; 18(10):532-4. PubMed ID: 15625829
[TBL] [Abstract][Full Text] [Related]
29. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
Dalle B; Payen E; Regulier E; Deglon N; Rouyer-Fessard P; Beuzard Y; Aebischer P
Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
[TBL] [Abstract][Full Text] [Related]
30. Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia.
Nualkaew T; Sii-Felice K; Giorgi M; McColl B; Gouzil J; Glaser A; Voon HPJ; Tee HY; Grigoriadis G; Svasti S; Fucharoen S; Hongeng S; Leboulch P; Payen E; Vadolas J
Mol Ther; 2021 Sep; 29(9):2841-2853. PubMed ID: 33940155
[TBL] [Abstract][Full Text] [Related]
31. [Optimization of β-globin Stable Expression Using the Third Generation Lentiviral Vector for β-thalassemia Therapy].
Yu Z; Tong S; Bai Y; Zhong XS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):844-850. PubMed ID: 35680815
[TBL] [Abstract][Full Text] [Related]
32. Unusually severe heterozygous beta-thalassemia: evidence for an interacting gene affecting globin translation.
Ho PJ; Hall GW; Watt S; West NC; Wimperis JW; Wood WG; Thein SL
Blood; 1998 Nov; 92(9):3428-35. PubMed ID: 9787184
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
Sadelain M
Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
[TBL] [Abstract][Full Text] [Related]
34. Relative and Absolute Quantification of Aberrant and Normal Splice Variants in
Patsali P; Papasavva P; Christou S; Sitarou M; Antoniou MN; Lederer CW; Kleanthous M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933098
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.
Phanthong P; Borwornpinyo S; Kitiyanant N; Jearawiriyapaisarn N; Nuntakarn L; Saetan J; Nualkaew T; Sa-Ngiamsuntorn K; Anurathapan U; Dinnyes A; Kitiyanant Y; Hongeng S
Stem Cells Transl Med; 2017 Apr; 6(4):1059-1069. PubMed ID: 28213976
[TBL] [Abstract][Full Text] [Related]
36. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy.
Persons DA; Allay ER; Sabatino DE; Kelly P; Bodine DM; Nienhuis AW
Blood; 2001 May; 97(10):3275-82. PubMed ID: 11342459
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Effects of Hematopoietic Stem Cell Derived From Gene-Edited Mice on β654-Thalassemia.
Lu D; Gong X; Guo X; Chen Y; Zhu Y; Fang Y; Cai Q; Xu M; Yang H; Li D; Zeng Y; Zeng F
Stem Cells; 2024 Mar; 42(3):278-289. PubMed ID: 38134938
[TBL] [Abstract][Full Text] [Related]
38. A novel frameshift mutation at codon 66 (HBB:c.del201A) in the β-globin gene leads to beta-thalassemia.
Yu N; Kim HR; Cha YJ; Park EK
Ann Hematol; 2011 Feb; 90(2):243-4. PubMed ID: 20532507
[No Abstract] [Full Text] [Related]
39. A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia.
Chen XW; Mo QH; Li Q; Zeng R; Xu XM
Ann Hematol; 2007 Sep; 86(9):653-7. PubMed ID: 17516066
[TBL] [Abstract][Full Text] [Related]
40. A novel homozygous point mutation at codon 82 (HBB:c.247A > T) in the beta-globin gene leads to thalassemia major.
Angalena R; Prabitha KN; Chaudhary AK; Bashyam MD; Jain S; Dalal AB
Int J Lab Hematol; 2010 Oct; 32(5):548-9. PubMed ID: 20136848
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
